후두경(Laryngoscopes) 시장은 2022년에 3억 달러였으며, 2023-2030년의 예측 기간에 CAGR 16.6%로 추이하며, 2030년에는 11억 달러에 이를 것으로 예측됩니다.
후두경은 직접 눈으로 성대를 확인하고 기관 내 튜브를 기관에 삽입하는 데 사용됩니다. 후두경 검사는 생리적 반사의 상당한 활성화를 유도하기 때문에 철저한 마취가 필요하며 호흡기, 심혈관 및 신경계 합병증이 발생할 가능성이 높습니다. 고혈압 환자, 임산부 고혈압 환자, 허혈성 심장 질환이 있는 사람이 가장 취약합니다. 전신 마취, 국소 마취제, 아트로핀 또는 정맥 리도카인과 같은 약물로 교감 부신 반응을 예방하고 기계적 자극을 최소화하면 부정적인 결과를 완화하는 데 도움이 될 수 있습니다.
또한 후두경 시장은 호흡기 질환 증가와 의료비의 확대을 억제하는 압력 증가, 고품질의 환자 케어에 대한 수요 증가, 저침습 수술에 대한 수요 증가 등 다양한 요인에 의해 주도되고 있습니다.
역학
후두암 유병률 상승
후두암 유병률의 증가는 예측 기간 동안 시장이 성장하는 데 도움이되는 중요한 주요 동인 중 하나입니다. 일반적인 후두 질환으로는 후두염, 성대 결절, 성대 폴립, 라인케 부종, 후두개 낭종 등이 있습니다. 또한 후두 질환의 유병률은 남성에서 더 높은 것으로 관찰되었습니다.
예를 들어, 미국 암 협회에 따르면 2023년에 미국에서 약 12,470건의 후두암(남성 9,990건, 여성 2,480건)이 새로 발생할 것으로 예상하고 있습니다. 후두암의 약 60%는 성문(성대가 있는 부위)에서 시작되며, 약 35%는 성문 위쪽의 성문상피(성대 위쪽)에서 발생합니다.
후두경 검사는 성대 또는 목구멍 주변 부위의 생검 샘플을 채취하여 암을 추가로 발견합니다. 따라서 후두 질환의 유병률 증가는 전 세계적으로 후두경 시장을 가속화 할 준비가되어 있으며 향후 증가 할 것으로 예상되어 예측 기간 동안 연구 된 시장의 성장을 주도 할 것으로 예상됩니다.
기술 발전 증가
기술 발전의 증가는 예측 기간 동안 시장 성장을 주도 할 것입니다. 예를 들어, 2023 년 1 월 Timesco Healthcare Ltd는 아랍 건강 2023에서 시각화 개선, 합병증 감소, 병원 전 환경에서 기관 삽관 성공률 향상을 목표로 새로운 Optima View 비디오 후두경을 출시했습니다.
이 혁신적인 시스템은 고해상도 카메라와 비디오 디스플레이 모니터를 갖추고 있어 선명한 색상 보정 출력을 제공합니다. 3.75인치 LCD 디스플레이는 180도 회전하고 110도 기울어지므로 여러 명의 시청자와 함께 쉽게 보고 교육할 수 있습니다.
후두경의 높은 가격
후두경 시장의 성장을 제한하는 주요 요인 중 하나는 비싼 비용과 보험 적용을 위한 우호적인 환급 정책의 부족으로 인해 신흥국에서 마취 비디오 후두경의 채택이 적다는 점입니다. 메드트로닉 통계에 따르면 재사용 가능한 기기의 비용은 기술 전문성에 따라 미화 1,000달러에서 8,000달러에 이르는 반면, 일회용 표준 후두경의 비용은 미화 18달러에 달합니다.
결과적으로 이러한 기기의 비싼 가격과 유지비는 시장 확대에 걸림돌이 될 수 있습니다. 동시에 기관 내 삽관을 위한 비용 효율적인 대체 기기의 가용성은 이 시장의 발전 잠재력을 가로막는 큰 장애물입니다.
Global laryngoscopes market reached US$ 0.3 billion in 2022 and is expected to reach US$ 1.1 billion by 2030 growing with a CAGR of 16.6% during the forecast period 2023-2030.
Laryngoscopes are used to see the vocal cords and insert the endotracheal tube into the trachea under direct eyesight. Since laryngoscopy induces substantial activation of physiologic reflexes, thorough anaesthesia is required, and respiratory, cardiovascular, and neurologic complications are likely. Hypertensive individuals, pregnant hypertensive patients, and people with ischemic heart disease are most vulnerable. Deep anaesthesia, topical anaesthetics, preventing the sympathoadrenal response with medications like atropine or intravenous lidocaine, and minimising mechanical stimulation can all help to mitigate the negative consequences.
Furthermore, the laryngoscopes market is driven by various factors like increasing respiratory diseases and growing pressure to reduce the rising healthcare costs, increasing need for high-quality patient care, and increasing demand for minimally invasive surgeries.
Dynamics
Rise in the prevalence of laryngeal cancer
The rise in the prevalence of laryngeal cancer is one of the significant key driver that helps the market to grow during the forecast period. Some common laryngeal diseases include laryngitis, vocal nodules, vocal polyps, Reinke's edema, and epiglottic cyst, among others. In addition, it has been observed that the prevalence of laryngeal disease is higher in males.
For instance, according to the American Cancer Society, it estimates in 2023, there will be about 12,470 new cases of laryngeal cancer (9,990 in men and 2,480 in women) in the United States. About 60% of laryngeal cancers start in the glottis (the area containing the vocal cords), while about 35% develop in the supraglottic area (above the vocal cords).
Laryngoscopy takes biopsy samples of the vocal cords or nearby parts of the throat to detect cancer further. Thus, the increasing prevalence of laryngeal disease is poised to accelerate the laryngoscope market globally and is expected to increase in the future, thereby driving the growth of the market studied over the forecast period.
Rise in Technological Advancements
A rise in technological advancement will drive market growth during the forecast period. For instance, in Jan 2023 Timesco Healthcare Ltd launched its new Optima View video laryngoscope at Arab Health 2023, aiming to improve visualisation, reduce complications, and improve tracheal intubation success rates in prehospital settings.
The innovative system features a high-resolution camera and video display monitor, offering clear, colour-correct output. The 3.75" LCD display rotates 180 degrees and tilts 110 degrees, allowing for easy viewing and teaching with multiple viewers.
High Cost of Laryngoscopes
One of the key factors limiting the growth of the laryngoscope market is the lesser adoption of anaesthesia video laryngoscopes in emerging nations due to expensive costs and a lack of favourable reimbursement policies to offer coverage. According to Medtronic statistics, the cost of reusable devices ranges from USD 1,000 to USD 8,000 depending on their technological speciality, compared to the cost of a single-use standard laryngoscope, which is USD 18.
As a result, the exorbitant prices of these gadgets, as well as their upkeep, are poised to stymie expansion. At the same time, the availability of cost-effective alternative devices for endotracheal intubations is a big impediment to this market's development potential.
The global laryngoscopes is segmented based on type, product, end user and region.
The Direct Laryngoscopes From the Type Segment Accounted for Approximately 42.1% of the Laryngoscopes Share
The direct laryngoscopes from the type segment with around 42.1% are expected to dominate during the forecast period. A direct laryngoscopy allows visualization of the larynx and is often used during general anaesthesia, surgical procedures around the larynx, and resuscitation. This tool is useful in multiple hospital settings, from the emergency department to the intensive care unit and the operating room.
This procedure is used during general anaesthesia, surgical procedures around the larynx, and resuscitation, and it facilitates endotracheal intubation, which is an important step for patients who are unable to secure their own airways. However, direct laryngoscopy should only be attempted if preparations are in place for an immediate surgical airway if intubation is unsuccessful.
Geographical Penetration
North America Accounted for Approximately 38.4% of the Market Share in 2022
North America is estimated to hold about 38.4 % of the total market share throughout the forecast period, owing to the new launches, increased investments by large corporations and expansion strategies like mergers, acquisitions, and the introduction of novel products by market participants.
For instance, in April 2023, Verathon, a global leader in airway management solutions, announced the launch of the GlideScope Spectrum QC with QuickConnect technology. This new, extensive portfolio of single-use video laryngoscopes features a unique, magnetic connector coupled with image quality enhancements to support fast, effective airway management.
The integration of QuickConnect technology with the market-leading GlideScope Spectrum video laryngoscopes further optimizes prep time for intubation procedures, especially important in emergent and difficult airway management situations. QuickConnect ensures the clinician can focus on the patient while utilizing the AlwaysConnect experience.
The major global players in the laryngoscopes market include Ambu A/S, Flexicare Medical, NOVAMED USA, Penlon Limited, Rudolf Riester GmbH, Medtronic plc, Propper Manufacturing Co. Inc, Teleflex Incorporated, Verathon Inc, KARL STORZ GmbH & Co and among others.
The COVID-19 epidemic had little influence on the laryngoscope market. The severe lockdowns and government measures enacted to halt the spread of COVID-19 resulted in a decrease in the number of patients seeking non-emergency care. COVID-19, on the other hand, largely impacted the respiratory system, resulting in an instant need for respiratory and vascular access equipment, such as laryngoscopes.
Furthermore, the UK Difficult Airway Society, the Association of Anaesthetists, the Intensive Care Society, and the Royal College of Anaesthetists have all recommended tracheal intubation with a video laryngoscope over a direct laryngoscope for patients with suspected or confirmed COVID-19 who require intubation.
Russia Ukraine Conflict Analysis
The Russia-Ukraine conflict is estimated to have a moderate impact on the global laryngoscopes market, owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of devices is expected to have little influence over the global laryngoscopes market growth over the forecast period.
By Type
By Product
By End User
By Region
U.S.
Canada
Mexico
Germany
U.K.
France
Spain
Italy
Rest of Europe
Brazil
Argentina
Rest of South America
China
India
Japan
Australia
Rest of Asia-Pacific
The global laryngoscopes report would provide approximately 53 tables, 54 figures and 195 pages.
LIST NOT EXHAUSTIVE